HUP9901021A2 - Famciklovirt nagy koncentrációban tartalmazó gyógyászati tabletták - Google Patents

Famciklovirt nagy koncentrációban tartalmazó gyógyászati tabletták

Info

Publication number
HUP9901021A2
HUP9901021A2 HU9901021A HUP9901021A HUP9901021A2 HU P9901021 A2 HUP9901021 A2 HU P9901021A2 HU 9901021 A HU9901021 A HU 9901021A HU P9901021 A HUP9901021 A HU P9901021A HU P9901021 A2 HUP9901021 A2 HU P9901021A2
Authority
HU
Hungary
Prior art keywords
famciclovir
content
pharmaceutical tablets
tablet
tablets
Prior art date
Application number
HU9901021A
Other languages
English (en)
Inventor
Michael John Greenway
Jennifer Mary Slater
Original Assignee
Smithkline Beecham Plc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc., filed Critical Smithkline Beecham Plc.,
Publication of HUP9901021A2 publication Critical patent/HUP9901021A2/hu
Publication of HUP9901021A3 publication Critical patent/HUP9901021A3/hu
Publication of HU225472B1 publication Critical patent/HU225472B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány gyógyászati tablettára vőnatkőzik, amely hatóanyagkéntfamciklővirt tartalmaz, és amelyben a famciklővir mennyisége atabletta össztömegére vőnatkőztatva 85 tömeg%, vagy annál nagyőbb. ŕ
HU9901021A 1996-01-16 1997-01-13 High-content famciclovir pharmaceutical tablets HU225472B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals
PCT/EP1997/000195 WO1997025990A1 (en) 1996-01-16 1997-01-13 High-content famciclovir tablets

Publications (3)

Publication Number Publication Date
HUP9901021A2 true HUP9901021A2 (hu) 1999-08-30
HUP9901021A3 HUP9901021A3 (en) 2000-08-28
HU225472B1 HU225472B1 (en) 2006-12-28

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901021A HU225472B1 (en) 1996-01-16 1997-01-13 High-content famciclovir pharmaceutical tablets

Country Status (38)

Country Link
US (1) US6765007B1 (hu)
EP (1) EP0874632B1 (hu)
JP (2) JP4711360B2 (hu)
KR (1) KR100338829B1 (hu)
CN (1) CN1132582C (hu)
AP (2) AP747A (hu)
AR (1) AR005456A1 (hu)
AT (1) ATE220910T1 (hu)
AU (1) AU713090B2 (hu)
BG (1) BG63488B1 (hu)
BR (1) BR9706982A (hu)
CY (1) CY2390B1 (hu)
CZ (1) CZ287205B6 (hu)
DE (1) DE69714215T2 (hu)
DK (1) DK0874632T3 (hu)
DZ (1) DZ2159A1 (hu)
EA (1) EA001946B1 (hu)
EG (1) EG23684A (hu)
ES (1) ES2180922T3 (hu)
GB (1) GB9600847D0 (hu)
HK (1) HK1016473A1 (hu)
HU (1) HU225472B1 (hu)
IL (1) IL124913A0 (hu)
MX (1) MX9805713A (hu)
MY (1) MY127527A (hu)
NO (1) NO315689B1 (hu)
NZ (1) NZ326769A (hu)
OA (1) OA10812A (hu)
PE (1) PE35498A1 (hu)
PL (1) PL187291B1 (hu)
PT (1) PT874632E (hu)
SK (1) SK282132B6 (hu)
TR (1) TR199800954T2 (hu)
TW (1) TW434016B (hu)
UA (1) UA63897C2 (hu)
UY (2) UY24437A1 (hu)
WO (1) WO1997025990A1 (hu)
ZA (1) ZA97310B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
CN102470237A (zh) 2009-06-26 2012-05-23 塔里斯生物医药公司 用于可植入药物递送装置的固体药物片剂
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
AU653203B2 (en) * 1991-01-30 1994-09-22 Wellcome Foundation Limited, The Water-dispersible tablets
CA2103050A1 (en) 1991-05-15 1992-11-16 Yung-Chi Cheng Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
NO983259D0 (no) 1998-07-15
AP9801298A0 (en) 1998-09-30
GB9600847D0 (en) 1996-03-20
PE35498A1 (es) 1998-08-07
BG63488B1 (bg) 2002-03-29
BR9706982A (pt) 1999-07-20
PL327922A1 (en) 1999-01-04
JP4711360B2 (ja) 2011-06-29
DK0874632T3 (da) 2002-11-11
AU713090B2 (en) 1999-11-25
BG102638A (en) 1999-07-30
AP1114A (en) 2002-10-18
CZ287205B6 (en) 2000-10-11
MX9805713A (es) 1998-10-31
PL187291B1 (pl) 2004-06-30
CY2390B1 (en) 2004-09-10
HU225472B1 (en) 2006-12-28
US6765007B1 (en) 2004-07-20
HUP9901021A3 (en) 2000-08-28
CZ225498A3 (cs) 1998-12-16
ZA97310B (en) 1997-10-23
EA199800573A1 (ru) 1999-02-25
UA63897C2 (en) 2004-02-16
WO1997025990A1 (en) 1997-07-24
OA10812A (en) 2003-01-29
CN1132582C (zh) 2003-12-31
HK1016473A1 (en) 1999-11-05
UY24437A1 (es) 1997-06-06
EA001946B1 (ru) 2001-10-22
NZ326769A (en) 2000-05-26
NO983259L (no) 1998-07-15
JP2009091362A (ja) 2009-04-30
KR100338829B1 (ko) 2002-07-18
SK95698A3 (en) 1999-01-11
AP9700911A0 (en) 1997-01-31
TW434016B (en) 2001-05-16
NO315689B1 (no) 2003-10-13
SK282132B6 (sk) 2001-11-06
ATE220910T1 (de) 2002-08-15
ES2180922T3 (es) 2003-02-16
IL124913A0 (en) 1999-01-26
EG23684A (en) 2007-05-09
AU1541897A (en) 1997-08-11
DE69714215T2 (de) 2003-01-23
AR005456A1 (es) 1999-06-23
AP747A (en) 1999-05-03
TR199800954T2 (xx) 1998-10-21
UY24556A1 (es) 2001-08-27
MY127527A (en) 2006-12-29
EP0874632A1 (en) 1998-11-04
DE69714215D1 (de) 2002-08-29
JP2000503311A (ja) 2000-03-21
PT874632E (pt) 2002-10-31
CN1208350A (zh) 1999-02-17
KR19990077229A (ko) 1999-10-25
DZ2159A1 (fr) 2002-12-01
EP0874632B1 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
DE69801369D1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
NO971206D0 (no) Forlenget-frigjöringsformulering
ZA964547B (en) Monkey monocional antibodies specific to human b7.1 and/or b7.2, primatized forms thereof pharmaceutical compositions containing them and use thereof as immunosuppressants
HUP9602601A3 (en) Piperidine and piperazine derivatives, medicines containing them as active ingredient and their use
FR2631233B1 (fr) Comprime de chlorhydrate de ranitidine enrobe
HU9501623D0 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug
DK1007006T3 (da) Formulering af cefadroxilmonohydrattablet
MY119722A (en) Swallow tablet comprising paracetamol.
FR2729857B1 (fr) Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
HUP0001780A2 (hu) Stabilizált tibolont tartalmazó készítmények és eljárás előállításukra
ATE122880T1 (de) Mehrfach teilbare tablettenstruktur.
HUP9901021A2 (hu) Famciklovirt nagy koncentrációban tartalmazó gyógyászati tabletták
DK0427124T3 (da) Antacidatabletter
HUP9902458A2 (hu) Nyújtott hatóanyag-leadású, mizolasztintartalmú gyógyszerkészítmények
MA26447A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
IS1914B (is) Ný LH-RH mótlyf, framleiðsla þeirra og notkun, ásamt læknislyfjum sem innihalda samsetningarnar og framleiðsla þeirra
NO991740D0 (no) Farmas°ytiske og kosmetiske formuleringer med antimikrobiell aktivitet
CA2240462A1 (en) High-content famciclovir tablets
DE3773128D1 (de) Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.
DE50006408D1 (de) Pharmazeutische zubereitung enthaltend dithranol
KR960033451A (ko) 나트륨 치환 트립토판을 포함하는 b형 간염 치료제
ECSP971997A (es) Nueva formulacion de un producto farmaceutico